Podcasts

Assessing Treatment-Relevant Immune Biomarkers

Featuring William Damsky, MD, PhD

07/24/2023

In this exclusive interview with The Dermatologist, Dr William Damsky discusses how immunologically targeted therapies revolutionized the treatment of inflammatory dermatoses following his study, “Assessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis”.

William Damsky, MD, PhD, is an assistant professor in Dermatology and Dermatopathology at Yale School of Medicine in New Haven, CT. He specializes in medical dermatology and dermatopathology with a specific focus in cutaneous granulomatous disorders.

Transcript coming soon.

© 2023 HMP Global. All Rights Reserved.

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of The Dermatologist or HMP Global, their employees, and affiliates.

Current Issue

October 2024

Volume 32

Issue 7

Current Issue

Issue Archive

Popular Articles

News

Brodalumab Superior to Ustekinumab on Health-Related Quality of Life for Patients with Psoriasis

12/17/2021

Allison Casey ;

A recent study compared the effects of 52 weeks of treatment with brodalumab or ustekinumab on HRQoL in patients with moderate to severe plaque psoriasis and found that patients on brodalumab had a significantly greater improvement.

A recent study compared the...

12/17/2021

The Dermatologist

Spotlight

SPOTLIGHT on Diya Mutasim, MD

01/09/2009

In dermatology, we are fortunate to have many of our profession’s innovators and great teachers still among us. This column was created so that we may gain insight from these practitioners and learn more about them. Some are bright stars in...

In dermatology, we are fortunate...

01/09/2009

The Dermatologist

FDA Alerts

Upadacitinib Approved for Patients with Moderate to Severe AD

01/15/2022

Lauren Mateja ;

Upadacitinib, an oral JAK1 inhibitor, was approved for the treatment of moderate to severe AD in patients aged 12 years and older.

Upadacitinib, an oral JAK1...

01/15/2022

The Dermatologist

CHALLENGE: Correction of Cheek Volume Loss

10/16/2008

Patient: A 56-year-old HIV-negative Caucasian male presented for a cosmetic correction of “sunken-in” cheeks. Treatment Issues: Using a calcium hydroxylapatite filler to correct mid-face volume loss.

Patient: A 56-year-old...

10/16/2008

The Dermatologist

Podcasts

Drs Green and Kaufmann Talk Navigating Billing Code Changes in 2022

02/08/2022

Lawrence Green, MD, and Mark Kaufmann, MD, discuss recent billing coding changes and what dermatologists need to know to navigate them in 2022.

Lawrence Green, MD, and Mark...

02/08/2022

The Dermatologist

The Dermatologist Newsletter

Latest Quizzes and Trivia

Quiz

Pediatric Atopic Dermatitis Management

11/11/2024

Riya Gandhi , MA;

1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...

1. What alternative therapies...

11/11/2024

The Dermatologist

QUIZ

Test Your Knowledge: The Immunology of Alopecia Areata

11/04/2024

The Dermatologist

Quiz

Long-Term Safety of Risankizumab

10/18/2024

Jessica Garlewicz ;

What were the primary findings regarding the long-term safety of risankizumab?

What were the primary findings...

10/18/2024

The Dermatologist

Quiz

Barriers to Mental Health Support

10/10/2024

Riya Gandhi , MA;

What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?

What was the first barrier to...

10/10/2024

The Dermatologist

Quiz

QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies

09/15/2024

Riya Gandhi , MA;

1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...

1. According to Dr Linda Stein...

09/15/2024

The Dermatologist

Quiz

QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis

08/10/2024

Riya Gandhi , MA;

What strategies did Dr Merola emphasize for atopic dermatitis?

What strategies did Dr Merola...

08/10/2024

The Dermatologist

contact dermtitis + Neck + Eczema + rash

Quiz

QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing

07/14/2024

What is a common challenge for patients during the patch testing week?

What is a common challenge for...

07/14/2024

The Dermatologist

Quiz

Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis

05/30/2024

Riya Gandhi , MA;

According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?

According to a recent interview...

05/30/2024

The Dermatologist

Quiz

Quiz: Atopic Dermatitis Spotlight

05/06/2024

Riya Gandhi , MA;

Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?

Which class of medications...

05/06/2024

The Dermatologist

Quiz

True or False: Basal Cell Carcinoma on Vermilion Lip

05/01/2024

Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?

Is basal cell carcinoma on the...

05/01/2024

The Dermatologist

Assessing Treatment-Relevant Immune Biomarkers

© 2023 HMP Global. All Rights Reserved.

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of The Dermatologist or HMP Global, their employees, and affiliates.

Current Issue

Popular Articles

Subscribe

Latest Quizzes and Trivia

Specialties

Events

Year Round Education

HMP Global Products